KC-6688

Jurkat-NFκB-Luc2-CTLA4 Cell Line

×
71235
Home » Jurkat-NFκB-Luc2-CTLA4 Cell Line

Background of Jurkat-NFκB-Luc2-CTLA4 Cell Line

CTLA4 encodes cytotoxic T-lymphocyte associated protein 4 and is also known as CD. The protein contains a V domain, a transmembrane domain, and a cytoplasmic tail. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. The membrane-bound isoform functions as a homodimer interconnected by a disulfide bond, while the soluble isoform functions as a monomer.

Specifications

Catalog NumberKC-6688
Cell Line NameJurkat-NFκB-Luc2-CTLA4 Cell Line
NCBI/UniProt Accession NumberNM_005214.5
Clone Number1B3
Host Cell LineJurkat-NFκB-Luc2
DescriptionJurkat-NFκB-Luc2-CTLA4 is a stable reporter cell line for studying NFκB, CTLA4
QuantityOne vial of frozen cells (≥2×10⁶ cells/vial)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing Medium70% RPMI1640+20% FBS+10% DMSO
Propagation MediumRPMI1640+10%FBS+10 μg/mL Blasticidin S
Selection MarkerBlasticidin S
MorphologyLymphoblast
SubcultureSplit at a ratio of 1:4–1:6 every 2–3 days
Incubation37 °C with 5% CO2
StorageLiquid nitrogen immediately upon receiving
Doubling TimeEstimated 19–36 hours
Mycoplasma StatusNegative
In Vivo ValidationNA

Cell Line Generation

Jurkat-NFκB-Luc2-CTLA4 Cell Line was generated using a lentiviral vector expressing the CTLA4 sequence.

Characterization

Figure 1: Jurkat-NFκB-Luc2-CTLA4 cells were seeded into 96-well plates and incubated, followed by treatment with Ipilimumab (Cat#KB-1103, Kyinno) for 30 min. Raji-OS8 cells were then added to the wells and co-cultured for 16 h, then luminescence was read out using the Bright-Glo Detection System.

Cell Resuscitation

  1. Pre-warm complete culture medium (basal medium and 10% FBS) in a 37°C water bath.
  2. Rapidly thaw the cryovial in a 37°C water bath for 1-2 minutes with gentle agitation.
  3. Transfer the vial to a biosafety cabinet, and disinfect the exterior with 70% ethanol.
  4. Aseptically transfer the cell suspension dropwise into a sterile centrifuge tube containing 9.0 mL of pre-warmed complete medium.
  5. Centrifuge at approximately 125 × g for 5–7 minutes at room temperature, carefully aspirate the supernatant without disturbing the cell pellet.
  6. Gently resuspend the pellet in an appropriate volume of complete medium and transfer the suspension into a T25 flask.
  7. Incubate the flask in a 37°C in a humidified 5% CO₂ incubator.
  8. Assess cell viability and morphology after 24 hours. If cells appear healthy, replace the medium with fresh medium supplemented with the appropriate selective antibiotic.
  9. Subculture the cells at a ratio of 1:4–1:6 every 2–3 days upon reaching 80%–90% confluency.

Cell Freezing

  1. Prepare the freezing medium (70% basal medium, 20% FBS and 10% DMSO) freshly before use.
  2. Pre-chill the freezing medium on ice and label the cryovials accordingly.
  3. Transfer the cell suspension to a sterile conical tube and perform a cell count to determine total viability and density.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature; carefully aspirate the supernatant.
  5. Gently resuspend the pellet in chilled freezing medium, ensuring a minimum cell density of 3×10⁶ cells/mL.
  6. Aliquot 1 mL of the cell suspension into each pre-labeled cryovial.
  7. Place the cryovials into a CoolCell® container and store at -80°C overnight for controlled-rate cooling.
  8. Transfer the cryovials to the liquid nitrogen for long-term storage the following day.

References

  1. Ma J, Hou Z Gut Microbiota-Immune-Inflammation Axis as a Putative Pathogenic Axis in Chronic Insomnia: Mechanistic Dissection of NLRP3 Inflammasome and NF-κB Signaling. International journal of general medicine. 2026;19:645057. PMID: 42857238. doi: 10.2147/IJGM.S645057.
  2. Cildir G, Cildir S, Erdogan RK et al. Immune Checkpoint Dysfunction Remodels Adaptive Immune Receptor Repertoires in CTLA-4 Insufficiency and LRBA Deficiency. Clinical reviews in allergy & immunology. 2026 Oct 19;69(1):. PMID: 42895678. doi: 10.1007/s12016-026-09209-8.
  3. Hasan F, Thippamma K, Kumar V et al. Natural Products Targeting Alzheimer's Disease via NF-κB Pathway: A Review. CNS & neurological disorders drug targets. 2026;25(8):645-660. PMID: 42841458. doi: 10.2174/0118715273397045250922054643.

Use License Agreement

Research Use Only.
Not for use in diagnostic procedures or therapeutic applications.
Redistribution of the cell line or its derivatives is prohibited without prior written permission from Kyinno Biotechnology.